Agenus Reports 48% Estimated Three-Year Survival With BOT+BAL in Recurrent Ovarian Cancer at IGCS 2026
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| AGENUS (NASDAQ: AGEN) | Delayed: 6.33 -0.18 (2.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.51 | 52 Week High | $7.49 | |||
| Open | $6.36 | 52 Week Low | $2.61 | |||
| Day High | $6.50 | P/E | N/A | |||
| Day Low | $6.16 | EPS | $-1.10 | |||
| Volume | 510,113 | |||||
